M. Scot Roberts
2022
In 2022, M. Scot Roberts earned a total compensation of $1.4M as Chief Scientific Officer at PharmAthene, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,000 |
|---|---|
| Option Awards | $572,395 |
| Salary | $425,000 |
| Stock Awards | $234,183 |
| Other | $4,255 |
| Total | $1,405,833 |
Roberts received $572.4K in option awards, accounting for 41% of the total pay in 2022.
Roberts also received $170K in non-equity incentive plan, $425K in salary, $234.2K in stock awards and $4.3K in other compensation.
Rankings
In 2022, M. Scot Roberts' compensation ranked 2,361st out of 5,676 executives tracked by ExecPay. In other words, Roberts earned more than 58.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,361 out of 5,676 | 58th |
Division Manufacturing | 1,290 out of 3,084 | 58th |
Major group Chemicals And Allied Products | 573 out of 1,399 | 59th |
Industry group Drugs | 528 out of 1,300 | 59th |
Industry Pharmaceutical Preparations | 379 out of 942 | 60th |
Source: SEC filing on August 16, 2023.
Roberts' colleagues
We found three more compensation records of executives who worked with M. Scot Roberts at PharmAthene in 2022.